Cognitive Impairment in Genetic Parkinson’s Disease
Author(s) -
A. Planas-Ballvé,
Dolores Vilas
Publication year - 2021
Publication title -
parkinson s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.748
H-Index - 46
eISSN - 2090-8083
pISSN - 2042-0080
DOI - 10.1155/2021/8610285
Subject(s) - parkin , lrrk2 , parkinson's disease , cognition , cognitive decline , pink1 , disease , cognitive impairment , medicine , neuroscience , psychology , genetics , dementia , biology
Cognitive impairment is common in idiopathic Parkinson’s disease (PD). Knowledge of the contribution of genetics to cognition in PD is increasing in the last decades. Monogenic forms of genetic PD show distinct cognitive profiles and rate of cognitive decline progression. Cognitive impairment is higher in GBA- and SNCA-associated PD, lower in Parkin- and PINK1-PD, and possibly milder in LRRK2-PD. In this review, we summarize data regarding cognitive function on clinical studies, neuroimaging, and biological markers of cognitive decline in autosomal dominant PD linked to mutations in LRRK2 and SNCA, autosomal recessive PD linked to Parkin and PINK1, and also PD linked to GBA mutations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom